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OBJECTIVES: Herniated discs and degenerative disc disease are major health problems worldwide. However,
their pathogenesis remains obscure. This study aimed to explore the molecular mechanisms of these ailments
and to identify underlying therapeutic targets.
MATERIAL AND METHODS: Using the GSE23130 microarray datasets downloaded from the Gene Expression
Omnibus database, differentially co-expressed genes and links were identified using the differentially co-
expressed gene and link method with a false discovery rate ,0.25 as a significant threshold. Subsequently, the
underlying molecular mechanisms of the differential co-expression of these genes were investigated using
Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis. In addition, the transcriptional
regulatory relationship was also investigated.
RESULTS: Through the analysis of the gene expression profiles of different specimens from patients with these
diseases, 539 differentially co-expressed genes were identified for these ailments. The ten most significant
signaling pathways involving the differentially co-expressed genes were identified by enrichment analysis.
Among these pathways, apoptosis and extracellular matrix-receptor interaction pathways have been reported
to be related to these diseases. A total of 62 pairs of regulatory relationships between transcription factors and
their target genes were identified as critical for the pathogenesis of these diseases.
CONCLUSION: The results of our study will help to identify the mechanisms responsible for herniated discs and
degenerative disc disease and provides a theoretical basis for further therapeutic study.
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& INTRODUCTION
The high prevalence of low back pain (LBP) makes disc
degeneration a leading health problem. Currently, 70-80% of
the adult population reports at least one episode of LBP
during their life (1). In the American population, the
incidence of symptomatic lumbar disc herniation is 1-2%,
and approximately 200,000 lumbar discectomies are per-
formed annually (2). Although there are several causes of
spinal pain, intervertebral discs (IVDs) appear to be the
most common source of chronic or recurring axial LBP (3).
IVD degeneration is defined as an aberrant cell-mediated
response to progressive structural failure and is a multi-
factorial process influenced by genetics, lifestyle, and
biomechanics (4).
Normal adult IVDs are made up of avascular tissue
composed of a large amount of extracellular matrix (ECM)
with a low cell density (approximately 1% of the total
volume). Small solutes, such as glucose, lactic acid, and
oxygen, in the inner parts of both the annulus fibrosus and
nucleus pulposus are mainly transported by diffusion. The
disc cells are responsible for maintaining the integrity of the
ECM (5). Changes in the metabolic balance of IVD cells
affect the quality and quantity of the ECM and its functional
properties, and these changes can therefore be related to
disc degeneration (6). Microscopically, disc degeneration is
characterized by cell proliferation, cell necrosis or apoptosis,
mucous degeneration, granular changes, and ingrowths of
nerves or blood vessels (4,6). Cell proliferation leads to
cluster formation, particularly in the nucleus pulposus (7).
A recent study indicated that genetics plays a crucial role in
disc degeneration, explaining 29-54% of the variance in
adult populations (8). Environmental factors, such as
mechanical loading and smoking, account for the remaining
variance, although not all factors have been identified.
In this study, the gene expression profiles of cells from
herniated discs and discs with signs of degenerative disc
disease, as well as data on transcription factors (TFs) and
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target genes, were analyzed to identify underlying signaling
pathways and critical molecules that regulate these path-
ways at the transcriptional level. Recently, a number of
methods, such as comparison and cluster analysis, have
been adopted to analyze gene expression. However, many
studies have reported that the identification of differentially
expressed genes using these analyses cannot reveal the
connections among various genes, and therefore, it is
important to obtain clusters of genes that are differentially
co-expressed, share common attributes and function colla-
boratively (9,10). Using a variety of analytical methods,
differentially co-expressed genes (DCGs) in cells from
herniated discs and from discs exhibiting signs of degen-
erative disc disease were analyzed using the DCGL package
(11,12) in R.
& MATERIALS AND METHODS
Microarray analysis
The transcription profile of GSE23130 was obtained from
the National Center for Biotechnology Information (NCBI)
Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.
gov/geo/). Based on the GPL1352 [U133_X3P] Affymetrix
Human X3P Array, the RNA expression profiles of IVD cells
from 23 patients with herniated discs or degenerative disc
disease were analyzed. The 23 tissue samples for the
microarray study consisted of one grade I, five grade II, nine
grade III, five grade IV, and three grade V herniated discs or
degenerative disc disease. All tissue samples were obtained
from the Cancer Institute Cooperative Tissue Network
(CHTN) or during surgeries.
The Affymetrix GeneChip Operating System (GCOS) was
used to calculate expression summaries with a target
intensity of 100 using Microarray Suite version 5.0 (MAS
5.0) (13). For completeness, the raw expression datasets
were processed into expression estimates using the robust
multiarray average method (14). The arrays were normal-
ized using global scaling.
Differentially co-expressed genes (DCGs) and links
(DCLs) were identified using the DCGL method (http://
cran.r-project.org/web/packages/DCGL/index.html) (11,12),
which was released as an R package that included two gene-
filtering functions (an expression-based filter and a variance-
based filter), three link-filtering functions (a systematic link
filter, a percent link filter and a qlink filter) and five differential
coexpression analysis functions (log ratio of connections
[LRC], average specific connection [ASC], weighted gene
coexpression network analysis [WGCNA], differential coex-
pression profile [DCp], and differential coexpression enrich-
ment [DCe]). These functions generally use gene expression
matrices (with genes in rows and samples in columns) as the
major input, and the ultimate output is genes ranked by p-
value. The p-values were adjusted for multiple comparisons
using the false discovery rate (FDR) of Benjamini and
Hochberg (15). An FDR-corrected p-values of 0.25 was used
as the threshold value for screening the DCGs. The DCe has an
additional output of classified DCLs.
KEGG pathway enrichment analysis
The Kyoto Encyclopedia of Genes and Genomes (KEGG)
is a collection of online databases of genomes, enzymatic
pathways, and biological chemicals (16). The PATHWAY
database records networks of molecular interactions in the
cells and variants that are specific to particular organisms
(http://www.genome.jp/kegg/). A total of 130 pathways
including 2,287 genes were collected from KEGG (updated
on 2011.06).
The Database for Annotation, Visualization and Integrated
Discovery (DAVID) (17), a high-throughput and integrated
data-mining environment, analyzes gene lists derived from
high-throughput genomic experiments. DAVID was used to
identify over-represented KEGG pathways based on the
hypergeometric distribution. p-values,0.05 were considered
statistically significant.
Analysis of transcription factors and their target
genes
According to the central dogma, a variety of methods can
lead to differential gene expression. Gene expression is
regulated by TFs at the transcriptional level. Therefore, the
roles of TFs were further analyzed using the acquired data.
Information on the chromosome region to which human TFs
bind was obtained from the UCSC database (http://
genome.ucsc.edu). Subsequently, the chromosome annota-
tions were downloaded from the NCBI database and
analyzed to acquire the gene information of the above
positions. Ultimately, a total of 210,000 regulatory pairs of
TFs and their target genes were obtained. These pairs were
then mapped to the above DCLs to determine the regulatory
relationship between TFs and our DCGs.
& RESULTS
Screening for differentially co-expressed genes
Using the DCGL method described above, the gene
expression profiles of cells from discs with signs of
degenerative disc disease and from herniated discs with
different degrees were analyzed, and genes with FDR,0.25
were considered DCGs. A total of 539 DCGs and 113,866
significantly related pairs of DCLs were selected. These
findings suggest that these selected DCGs and their
connections may have crucial roles in the development of
herniated discs and degenerative disc disease.
Analysis of biological pathways related to
herniated discs and degenerative disc disease
A total of 539 DCGs were included in the KEGG pathway
enrichment analysis, and significantly altered pathways
were ranked according to their p-values. The results showed
that these DCGs were mainly involved in the following
pathways (Table 1): protein processing in endoplasmic
reticulum, Alzheimer’s disease, focal adhesion, glycosphin-
golipid biosynthesis-globo series, Huntington’s disease,
Parkinson’s disease, oxidative phosphorylation, apoptosis,
renal cell carcinoma, and selenoamino acid metabolism.
Therefore, further analysis of these pathways may explain
the pathogenesis of herniated discs and degenerative disc
disease to some extent. The analysis of the apoptosis and
ECM-receptor interaction pathways in particular may yield
important insights because these pathways have been
identified in previous studies.
Analysis of gene regulatory relationships
A total of 113,866 pairs of DCLs were matched with their
already known TFs and their target genes, and 62 pairs of
gene regulatory relationships (including 44 target genes)
were found to be associated with herniated discs and
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degenerative disc disease (Figure 1). This result indicated
that the presence of these 62 pairs of gene regulatory
relationships may lead to the differential expression of 44
target genes at the transcriptional level and ultimately result
in the progression of disc herniation and of degenerative
disc disease.
& DISCUSSION
Based on our results described above, 539 DCGs were
selected and shown to be enriched in several pathways in
degenerative disc disease and herniated discs of different
degrees. Among these pathways, apoptosis and ECM-
receptor interaction (5) were demonstrated to be associated
with these diseases. Both apoptosis and Fas/FasL expres-
sion have been reported to be present in human disc
specimens (18,19). The Fas/FasL system is a surface ligand
that leads to rapid cell death when a Fas-expressing cell
interacts with a second cell carrying the FasL receptor. Fas
expression is not observed in normal discs but can be
observed following disc injury, leading to disc degeneration
(20).
In addition, 113,866 pairs of DCLs were selected and
matched with their known TFs and target genes. Finally, 62
pairs of regulatory relationships that led to the identification
of differentially expressed genes associated with degenera-
tive disc disease and herniated discs of different degrees
were obtained. There were numerous biological regulatory
relationships between TFs and target genes (Figure 1). When
the TFs were DCGs, some of their target genes were DCGs
and some were not, indicating that many other factors were
synergistically involved in the regulation of these target
genes. However, although the TFs were not DCGs, all of
their target genes were DCGs. These TFs may regulate their
target genes through changes in their spatial structures and
configurations and changes in localization. For example,
NF-eˆB TFs are kept inactive in the cytoplasm by IeˆB
Table 1 - KEGG pathway enrichment analysis of
differentially co-expressed genes.
ID p-value Count Size Term
4141 0.0011 11 167 Protein processing in endoplasmic reticulum
5010 0.0012 11 168 Alzheimer’s disease
4510 0.0015 12 201 Focal adhesion
603 0.0032 3 14 Glycosphingolipid biosynthesis - globo series
5016 0.0074 10 184 Huntington’s disease
5012 0.0087 8 132 Parkinson’s disease
190 0.0094 8 134 Oxidative phosphorylation
4210 0.0130 6 88 Apoptosis
5211 0.0190 5 70 Renal cell carcinoma
450 0.0191 3 26 Selenoamino acid metabolism
5213 0.0275 4 52 Endometrial cancer
4512 0.0380 5 84 ECM-receptor interaction
5221 0.0433 4 60 Acute myeloid leukemia
5215 0.0469 5 89 Prostate cancer
511 0.0478 2 16 Other glycan degradation
5210 0.0480 4 62 Colorectal cancer
ID represents the identification number in the KEGG database; count
represents the number of differentially co-expressed genes involved in
this signaling pathway; size represents the number of total genes
included in this pathway; and term represents the name of this KEGG
pathway.
Figure 1 - Networks of transcription factors and their target genes included in set of 539 differentially co-expressed genes. Blue dots
represent target genes, and red dots represent transcription factors. The larger dots represent differentially co-expressed genes, and
the smaller dots represent genes that are not differentially co-expressed.
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(inhibitors of NF-eˆB) proteins (21). The activation process is
regulated by the IeˆB kinase (IKK) complex. IKK activation
leads to the phosphorylation and degradation of IeˆB
proteins, subsequent NF-eˆB nuclear translocation and the
transcriptional initiation of NF-eˆB-dependent genes (22).
Although the amount of TF (NF-eˆB) is not changed, the
activated TF can regulate its target genes and lead to their
differential expression.
In addition to these connections between TFs and target
genes, many differentially expressed genes could still be
regulated by TFs in indirect ways. For example, cathepsin K
gene expression is significantly higher in more degenerated
grade III to IV discs compared with healthier grade I to II
discs (p= 0.001) (23). Cathepsin K, the protein encoded by
CTSK, is a lysosomal cysteine protease involved in bone
remodeling and resorption (24,25). Mice that are deficient in
the cathepsin K gene have osteopetrosis of the long bones
and vertebrae and abnormal joint morphology (26).
Mutations in the human cathepsin K gene have been
demonstrated to be associated with a rare skeletal dysplasia
and pycnodysostosis (27,28). Cathepsin K over-expression
could lead to Gaucher disease (29). In an analysis of CTSK,
we found that CTSK could interact with the aryl hydro-
carbon receptor (AHR) after interactions between eukaryotic
translation initiation factor 2-alpha kinase 1 (EIF2AK) and
ras homolog family member G (RHOG). The AHR protein
contains several domains that are critical for its function and
is classified as a member of the basic helix-loop-helix/Per-
Arnt-Sim (bHLH/PAS) family of TFs (30,31). Therefore,
although there is no direct relationship between CTSK and
TFs, as shown in in Figure 1, CTSK can be regulated through
interactions with other molecules (AHR-.RHOG---
EIF2AK1---CTSK). It can be inferred that CTSK can be
regulated by several types of upstream genes, resulting in
differential expression.
In conclusion, DCGs and the corresponding pathways,
such as apoptosis and ECM-receptor interaction, were
demonstrated to be involved in degenerative disc disease
and herniated discs of different grades. Additionally, critical
regulatory relationships between TFs and target genes,
including one gene and several upstream regulators, were
also identified in our study. Further experiments will be
necessary to confirm these conclusions.
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